{"id":"https://openalex.org/W2002066433","doi":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-09","title":"Abstract P6-12-09: Targeting deregulated cyclin E in inflammatory breast cancer via sequential combination therapy","display_name":"Abstract P6-12-09: Targeting deregulated cyclin E in inflammatory breast cancer via sequential combination therapy","publication_year":2013,"publication_date":"2013-12-15","ids":{"openalex":"https://openalex.org/W2002066433","doi":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-09","mag":"2002066433"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs13-p6-12-09","doi":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-09","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-09","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070852357","display_name":"Angela Alexander","orcid":"https://orcid.org/0000-0002-6649-7991","observed_orcids":["https://orcid.org/0000-0002-6649-7991"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Alexander","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011734599","display_name":"Cansu Karaka\u015f","orcid":"https://orcid.org/0000-0003-0357-5224","observed_orcids":["https://orcid.org/0000-0003-0357-5224"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Karakas","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103262591","display_name":"Yun Gong","orcid":"https://orcid.org/0000-0002-7607-7712","observed_orcids":["https://orcid.org/0000-0002-7607-7712"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y Gong","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051758545","display_name":"Ricardo Alvarez","orcid":"https://orcid.org/0000-0001-6236-5230","observed_orcids":["https://orcid.org/0000-0001-6236-5230"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Alvarez","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088814426","display_name":"Naoto Tada Ueno","orcid":"https://orcid.org/0000-0002-0166-7275","observed_orcids":["https://orcid.org/0000-0002-0166-7275","https://orcid.org/0000-0001-7104-0673"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"NT Ueno","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Keyomarsi","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"24_Supplement","first_page":"P6","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7832000255584717,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7832000255584717,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.11509999632835388,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.06400000303983688,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inflammatory-breast-cancer","display_name":"inflammatory breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cyclin-e","display_name":"cyclin E","score":0.9760000109672546},{"id":"https://openalex.org/keywords/low-molecular-weight-cyclin-e","display_name":"low molecular weight cyclin E","score":0.9570000171661377},{"id":"https://openalex.org/keywords/cdk2-inhibitors","display_name":"CDK2 inhibitors","score":0.9160000085830688},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8199999928474426},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8730000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5899999737739563},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/isobologram-analysis","display_name":"isobolographic analysis","score":0.9610000252723694},{"id":"https://openalex.org/keywords/cell-cycle-dysregulation","display_name":"cell cycle dysregulation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7419999837875366},{"id":"https://openalex.org/keywords/breast-cancer-treatment","display_name":"breast cancer treatment","score":0.36000001430511475}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7859317660331726},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7280948162078857},{"id":"https://openalex.org/C2780839634","wikidata":"https://www.wikidata.org/wiki/Q5922406","display_name":"Inflammatory breast cancer","level":4,"score":0.6387560367584229},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5373676419258118},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.5341094732284546},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5251714587211609},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5084213614463806},{"id":"https://openalex.org/C94561458","wikidata":"https://www.wikidata.org/wiki/Q24724860","display_name":"Cyclin E","level":5,"score":0.5024759769439697},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.4983046054840088},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.46607470512390137},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42225149273872375},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42044854164123535},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.41551920771598816},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4151672124862671},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.36217111349105835},{"id":"https://openalex.org/C199835354","wikidata":"https://www.wikidata.org/wiki/Q15311861","display_name":"Cyclin D1","level":4,"score":0.29189860820770264},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1428086757659912},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs13-p6-12-09","doi":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-09","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs13-p6-12-09","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2573829268","https://openalex.org/W4401876931","https://openalex.org/W2010421788","https://openalex.org/W2155248649","https://openalex.org/W140741639","https://openalex.org/W2032166811","https://openalex.org/W4393095966","https://openalex.org/W4362592431","https://openalex.org/W2992207579","https://openalex.org/W4409625466"],"abstract_inverted_index":{"Abstract":[0,462],"Inflammatory":[1],"breast":[2,12,19,27,125,259],"cancer":[3,28],"(IBC)":[4],"is":[5,83,289,295,378,409],"a":[6,131,136,185,229,305,374,410],"rare,":[7],"highly":[8],"aggressive":[9,58],"form":[10],"of":[11,17,26,56,72,80,113,138,177,194,212,219,232,287,293,307,335,434,449,451],"cancer,":[13],"accounting":[14],"for":[15,283,337,431],"2-5%":[16],"all":[18],"cancers":[20,126],"in":[21,94,122,143,183,228,242,314,358,413],"the":[22,41,45,144,155,174,179,192,291,326,447],"US":[23],"and":[24,65,128,251,297,317,360],"10%":[25],"deaths.":[29],"Unfortunately,":[30],"until":[31],"recently":[32],"this":[33,81],"disease":[34],"has":[35,106],"not":[36],"been":[37],"studied":[38],"extensively":[39],"at":[40],"molecular/cellular":[42],"level":[43],"despite":[44],"compelling":[46],"unmet":[47],"need":[48],"to":[49,84,169,190,240,245,248,257,310,332,390],"develop":[50],"more":[51],"effective":[52],"therapies.":[53],"In":[54],"spite":[55],"receiving":[57],"multidisciplinary":[59],"therapy":[60],"(anthracycline-taxane-based":[61],"neoadjuvant":[62],"chemotherapy,":[63],"modified-radical-mastectomy":[64],"adjuvant":[66],"radiation":[67],"therapy),":[68],"only":[69,272],"about":[70],"40%":[71],"IBC":[73,261,359,415],"patients":[74],"survive":[75],"5":[76],"years.":[77],"The":[78,320],"goal":[79],"project":[82],"identify":[85],"new":[86],"targets":[87],"that":[88,118,162,370,406,417,437],"can":[89,263],"be":[90,264,442],"exploited":[91],"pharmacologically":[92],"either":[93],"combination":[95,387],"with":[96,100,304,355,384],"current":[97],"therapies":[98],"or":[99,267,274],"other":[101,292],"novel":[102],"agents.":[103],"Previous":[104],"work":[105],"identified":[107],"tumor-specific":[108],"low":[109],"molecular":[110],"weight":[111],"forms":[112],"cyclin":[114,180,209,419],"E,":[115,210],"termed":[116],"LMW-E,":[117],"are":[119,167,224,271,352],"preferentially":[120,141],"found":[121],"triple":[123],"negative":[124],"(TNBC)":[127],"serve":[129],"as":[130,393],"poor":[132],"prognostic":[133],"biomarker.":[134],"As":[135],"result":[137],"cleavage,":[139],"LMW-E":[140,166,220],"accumulates":[142],"cytoplasm":[145],"where":[146],"it":[147],"exerts":[148],"its":[149],"pleiotropic":[150],"oncogenic":[151],"functions":[152],"including":[153],"deregulating":[154],"cell":[156,253,276,281,300,348,362,391,452],"cycle.":[157],"Furthermore,":[158,386],"we":[159,323,367,427],"have":[160,344,368],"shown":[161],"TNBC":[163,266],"cells":[164,351],"harboring":[165],"sensitive":[168],"CDK":[170,308,356,371],"inhibitors.":[171],"To":[172],"establish":[173],"clinical":[175,439],"relevance":[176],"targeting":[178,407,454],"E/CDK2":[181],"axis":[182],"IBC,":[184],"pilot":[186],"study":[187],"was":[188,330],"performed":[189,197],"determine":[191,246],"incidence":[193],"LMW-E.":[195],"We":[196,278,343],"IHC":[198],"on":[199],"11":[200],"post-chemotherapy":[201],"surgical":[202],"specimens":[203],"from":[204],"MDACC.":[205],"All":[206],"tumors":[207,262,416],"expressed":[208],"8":[211],"which":[213,288,294,377],"had":[214],"predominantly":[215],"cytoplasmic":[216],"staining,":[217],"indicative":[218],"expression.":[221],"These":[222,234,299],"results":[223,237],"now":[225],"being":[226],"validated":[227],"larger":[230],"cohort":[231],"samples.":[233],"promising":[235,411],"preliminary":[236],"led":[238],"us":[239],"perform":[241],"vitro":[243],"experiments":[244],"sensitivity":[247,313],"CDK2":[249,408],"inhibitors":[250,309,372],"characterize":[252],"cycle":[254,453],"profiles.":[255],"Similar":[256],"non-IBC":[258,361],"cancers,":[260],"ER-positive,":[265],"HER2-overexpressing;":[268],"however,":[269,426],"there":[270],"TN-IBC":[273],"HER2+":[275],"lines.":[277,363],"utilized":[279],"2":[280],"lines":[282,301],"these":[284,401,422],"studies,":[285],"one":[286],"TN-IBC,":[290],"ER-negative":[296],"HER2-overexpressing.":[298],"were":[302],"treated":[303,354],"panel":[306],"evaluate":[311],"their":[312],"both":[315],"short-term":[316],"long-term":[318,321],"assays.":[319],"assay":[322,329],"developed":[324],"called":[325],"high-throughput":[327],"survival":[328],"used":[331],"examine":[333],"combinations":[334],"agents":[336],"potential":[338],"synergies":[339],"using":[340],"isobologram":[341],"analysis.":[342],"demonstrated":[345,369,428],"chemotherapy-specific":[346],"synergistic":[347],"death":[349],"when":[350],"first":[353],"inhibitor":[357],"Using":[364],"flow":[365],"cytometry,":[366],"induce":[373],"G2/M":[375],"arrest,":[376],"further":[379],"increased":[380],"by":[381,395],"sequential":[382],"treatment":[383,388],"chemotherapy.":[385],"leads":[389],"death,":[392],"measured":[394],"sub-G1":[396],"DNA":[397],"content.":[398],"Taken":[399],"together,":[400],"studies":[402,440],"provide":[403],"solid":[404],"evidence":[405],"strategy":[412],"treating":[414],"express":[418],"E.":[420],"Beyond":[421],"early":[423],"pre-clinical":[424],"advances,":[425],"clear":[429],"sequence-specificity":[430],"certain":[432],"pairs":[433],"drugs,":[435],"implying":[436],"future":[438],"should":[441],"designed":[443],"taking":[444],"into":[445],"account":[446],"mechanism":[448],"action":[450],"drugs.":[455],"Citation":[456],"Information:":[457],"Cancer":[458],"Res":[459],"2013;73(24":[460],"Suppl):":[461],"nr":[463],"P6-12-09.":[464]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}